Publications by authors named "T P Todorov"
Recently a resurgence of has arisen, with concerns around the highly virulent M1 lineage. Our aim was to characterize , the immune responses it causes, and to determine the presence of the M1 lineage in Sofia, Bulgaria. In our study, the infections were confirmed by culture testing or rapid antigen test.
View Article and Find Full Text PDFA quantum-electrodynamics approach is presented to describe the dynamics of electrons that exchange energy with both photon and phonon baths. Our ansatz is a dissipative quantum Liouville equation, cast in the Redfield form, with two driving terms associated with radiative and vibrational relaxation mechanisms, respectively. Remarkably, within the radiative contribution, there is a term that exactly replicates the expression derived from a semiclassical treatment where the power dissipated by the electronic density is treated as the emission from a classical dipole [Bustamante et al.
View Article and Find Full Text PDFTreatment for asthma and chronic obstructive pulmonary disease (COPD) is compromised, quality of life is negatively impacted, and significant financial losses result from nonadherence to the prescribed therapy.
View Article and Find Full Text PDFPiezoresistive microcantilever sensors for the detection of viruses, pathogens, and trace chemical gasses, with appropriate measurement and signal processing methods, can be a powerful instrument with high speed and sensitivity, with in situ and real-time capabilities. This paper discusses a novel method for mass sensing on the order of a few femtograms, using a dual-microcantilever piezoresistive sensor with a vibrating common base. The two microcantilevers have controllably shifted natural frequencies with only one of them being active.
View Article and Find Full Text PDFArticle Synopsis
- * Results showed that the minor T allele is more frequent in patients with sALS than in control groups, indicating a potential link to increased disease susceptibility.
- * However, the impact of this variant on the age at which symptoms begin was inconclusive, suggesting that while T allele carriers might experience symptoms around 2.5 years earlier, the findings need to be verified with larger sample sizes.